Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer

Objectives To determine the extracellular volume (ECV) fraction derived from equilibrium contrast-enhanced CT for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT) in locally advanced rectal cancer (LARC). Methods The ECV fraction before NCRT (ECV pre) and/or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European radiology 2023-06, Vol.33 (6), p.4042-4051
Hauptverfasser: Luo, Yuesheng, Liu, Leilei, Liu, Daihong, Shen, Hesong, Wang, Xiaoxia, Fan, Chunbo, Zeng, Zhen, Zhang, Jing, Tan, Yong, Zhang, Xiaoyue, Wu, Jiaxing, Zhang, Jiuquan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To determine the extracellular volume (ECV) fraction derived from equilibrium contrast-enhanced CT for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT) in locally advanced rectal cancer (LARC). Methods The ECV fraction before NCRT (ECV pre) and/or ECV after NCRT (ECV post ) of rectal tumors was assessed, and ECV Δ was calculated as ECV post − ECV pre . The histopathologic tumor regression grading (TRG) was assessed. pCR (TRG 0 grade) was defined as the absence of viable tumor cells in the primary tumor and lymph nodes. Demographic and clinicopathological characteristics and ECV fraction were compared between the pCR and non-pCR groups. A mixed model was constructed by logistic regression. The performance for predicting pCR was assessed with the area under the receiver-operator curve (AUC). The AUCs of the different methods were compared by the method proposed by DeLong et al. Results Seventy-five patients were included; 17 achieved pCR, and 58 achieved non-pCR. The ECV post (17.05 ± 2.36% vs. 29.94 ± 1.20%; p < 0.001) and ECV Δ (− 17.01 ± 3.01% vs. 0.44 ± 1.45%; p < 0.001) values in the pCR group were significantly lower than those in the non-pCR group. The mixed model that combined ECV post with ECV Δ achieved an AUC of 0.92 (95% confidence interval (CI) = 0.81–0.98), which was higher than that of ECV post (AUC, 0.91 (95% CI = 0.80–0.97); p = 0.60) or ECV Δ (AUC, 0.90 (95% CI = 0.79–0.97); p = 0.61). Conclusions ECV post and ECV Δ determined by using equilibrium contrast-enhanced CT were useful in distinguishing between pCR and non-pCR patients with LARC who received NCRT. Key Points • ECV post and ECV Δ (ECV post − ECV pre ) differed significantly between the non-pCR and pCR groups. • ECV pre cannot be used to predict the efficacy of neoadjuvant chemoradiotherapy. • ECV post combined with ECV Δ had the best performance with an AUC of 0.92 for predicting pCR after NCRT in LARC.
ISSN:1432-1084
0938-7994
1432-1084
DOI:10.1007/s00330-022-09307-z